Unproven methods of cancer treatment: Rand coupled fortified antigen (RCFA) and delayed double diffusion (3-D) test
Article first published online: 30 DEC 2008
Copyright © 1969 American Cancer Society
CA: A Cancer Journal for Clinicians
Volume 19, Issue 4, pages 251–254, July/August 1969
How to Cite
(1969), Unproven methods of cancer treatment: Rand coupled fortified antigen (RCFA) and delayed double diffusion (3-D) test. CA: A Cancer Journal for Clinicians, 19: 251–254. doi: 10.3322/canjclin.19.4.251
- Issue published online: 30 DEC 2008
- Article first published online: 30 DEC 2008
- 1At last! Scientists report anti-cancer vaccine. Pageant, December, 1966.:
- 2The latest report on the new anti-cancer vaccine. Pageant, January, 1967.:
- 3New vaccine for cancer. Drug News Weekly, December 26, 1966.
- 4Cleveland Plain Dealer, August 20, 1966.: New cancer vaccine held safe by Rand.
- 6New cancer weapon is tested here. Cleveland Press, July 12, 1962.:
- 7Blood test for cancer fails the initial trials at Federal Health Unit. Method was not “consistent” in diagnosing disease, says Arm of Public Health Service. Wall Street Journal, January 8, 1965.
- 8U.S. restricts cancer vaccine shipment. Washington Post, December 27, 1966.:
- 9SEC suspends trading in Rand Development pending clarification of its cancer vaccine. Market briefs. Business Week, January 28, 1967; p. 149.
- 10U.S. scores maker of Rand vaccine. Permanent injunction asked against cancer serum. New York Times, February 18, 1967.:
- 11Medical Lab, July, 1968.: A serological test for cancer.
- 12Rand Development, its president, indicted over cancer vaccine. Charges include mailing false reports about controversial drug and stock manipulation. Wall Street Journal, December 16, 1968.